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Abstract
Mendelian randomization uses genetic variants to make causal inferences about the
effect of a risk factor on an outcome. With fine-mapped genetic data, there may
be hundreds of genetic variants in a single gene region any of which could be used
to assess this causal relationship. However, using too many genetic variants in the
analysis can lead to spurious estimates and inflated Type 1 error rates. But if only a
few genetic variants are used, then the majority of the data is ignored and estimates
are highly sensitive to the particular choice of variants. We propose an approach
based on summarized data only (genetic association and correlation estimates) that
uses principal components analysis to form instruments. This approach has desirable
theoretical properties: it takes the totality of data into account and does not suffer
from numerical instabilities. It also has good properties in simulation studies: it is not
particularly sensitive to varying the genetic variants included in the analysis or the
genetic correlation matrix, and it does not have greatly inflated Type 1 error rates.
Overall, the method gives estimates that are not so precise as those from variable se-
lection approaches (such as using a conditional analysis or pruning approach to select
variants), but are more robust to seemingly arbitrary choices in the variable selection
step. Methods are illustrated by an example using genetic associations with testos-
terone for 320 genetic variants to assess the effect of sex hormone-related pathways on
coronary artery disease risk, in which variable selection approaches give inconsistent
inferences.
Keywords: Mendelian randomization, allele score, correlated variants, summarized
data, conditional analysis.
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Background
In a Mendelian randomization investigation, genetic variants that are instrumental
variables for a given risk factor are used to assess the causal effect of the risk factor
on an outcome [Davey Smith and Ebrahim, 2003; Burgess and Thompson, 2015]. An
association between such a genetic variant and the outcome is indicative of a causal
effect of the risk factor on the outcome [Didelez and Sheehan, 2007; Lawlor et al.,
2008]. When there are multiple uncorrelated genetic variants that are instrumental
variables for the same risk factor, power to detect a causal effect is maximized by
including all such genetic variants in a single analysis [Pierce et al., 2011]. However,
when genetic variants are correlated, it is not clear how to choose which variants
to include in the analysis to obtain the most efficient estimate possible without the
analysis suffering from numerical instabilities when there are large numbers of highly-
correlated candidate variants (such as with fine-mapped genetic data).
Theoretical viewpoint
If individual-level data are available on the genetic variants (potentially correlated),
risk factor, and outcome for the same participants, then the two-stage least squares
(2SLS) method provides the most efficient estimate of the causal effect (amongst
all instrumental variable estimators using linear combinations of the instruments and
under conditional homoscedasticity – the error term in the model relating the outcome
to the risk factor has constant variance conditional on the instruments) [Wooldridge,
2009].
The first stage of the 2SLS method regresses the risk factor on all the genetic
variants. As the sample size increases, the coefficient of any variant that does not
explain independent variation in the risk factor will tend to zero, and so its con-
tribution to the analysis decreases to zero. This implies that an optimally-efficient
Mendelian randomization analysis should include all genetic variants associated with
the risk factor in a conditional analysis. The inclusion of additional variants not in-
dependently associated with the risk factor will not have a negative impact on the
analysis asymptotically (as their coefficient for contribution to the analysis will tend
to zero), but will not add to the precision of the causal estimate either. As an aside,
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fitted values from the first-stage of the 2SLS method are equivalent (up to an additive
constant) to values of an allele score (also called a genetic risk score). This implies
that the optimal weights in an allele score with correlated variants are the conditional
(multivariable) associations of the variants with the risk factor.
Estimating a causal effect using summarized data
The 2SLS estimate can also be obtained using summarized data on genetic associa-
tions with the risk factor and with the outcome from univariable regression analyses
of the risk factor or outcome on each genetic variant in turn. This is important
as such summarized data from large consortia are often publicly available, enabling
Mendelian randomization investigations to be performed on large sample sizes with-
out the need for costly and time-consuming data-sharing arrangements [Burgess et al.,
2015b]. This estimate can also be calculated in a two-sample setting, in which ge-
netic associations with the risk factor and with the outcome are estimated in different
samples [Inoue and Solon, 2010].
If the genetic association with the risk factor for genetic variant j is βˆXj with
standard error se(βˆXj), and with the outcome is βˆY j with standard error se(βˆY j), and
assuming that genetic variants are uncorrelated, then the causal estimate is [Johnson,
2013]:
Inverse-variance weighted estimate (uncorrelated variants) =
∑
j βˆY j βˆXj se(βˆY j)
−2
∑
j βˆXj
2 se(βˆY j)−2
.
(1)
This is referred to as the inverse-variance weighted (IVW) estimate [Burgess et al.,
2013]. It is the weighted mean of the 2SLS estimates using each genetic variant
individually (
βˆY j
βˆXj
) with the inverse-variance weights
[
se(βˆY j)
βˆXj
]
−2
. The variant-specific
estimates are combined using the standard formula for a fixed-effect meta-analysis
[Borenstein et al., 2009]. This same estimate can be obtained by weighted regression of
the genetic associations with the outcome βˆY j on the genetic associations with the risk
factor βˆXj using weights se(βˆY j)
−2 and with the intercept term set to zero. The IVW
estimate is equivalent to the 2SLS estimate when the genetic variants are uncorrelated
[Burgess et al., 2015a]. This formula does not take into account uncertainty in the
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genetic associations with the risk factor; however, these associations are typically more
precisely estimated than those with the outcome, and ignoring this uncertainty does
not lead to inflated Type 1 error rates for the IVW estimate in realistic scenarios
[Burgess et al., 2013].
When genetic variants are correlated, the IVW method can be extended to ac-
count for the correlations between genetic variants [Burgess et al., 2016]. This can be
motivated by considering generalized weighted linear regression of the genetic asso-
ciations with the outcome on the genetic associations with the risk factor using the
weighting matrix Ω, where Ωj1j2 = se(βˆY j1) se(βˆY j2)ρj1j2, and ρj1j2 is the correlation
between genetic variants j1 and j2. The causal estimate is:
Inverse-variance weighted estimate (correlated variants) = (βˆ
T
XΩ
−1βˆX)
−1βˆ
T
XΩ
−1βˆY
(2)
where βˆX , βˆY are vectors of the genetic associations, and
T is a vector transpose.
Again, this estimate is equivalent to the 2SLS estimate that is obtained using individual-
level data (see Appendix for proof). It therefore inherits the efficiency property of
the 2SLS estimate as the optimally-efficient causal estimate based on all the genetic
variants.
Scope of paper
In this paper, we illustrate and provide guidance on choosing variants to include
in a Mendelian randomization with fine-mapped genetic data. We first provide a
motivating example analysis based on summarized genetic associations for hundreds
of correlated genetic variants in a single gene region. We demonstrate and explain
why including too many genetic variants in such an analysis can lead to numerical
instabilities and inflated Type 1 error rates. We also show that estimates based on a
few variants can be highly sensitive to the choice of these variants. A novel approach
is presented using principal components analysis to ensure that all variants contribute
to the analysis, but without introducing numerical instabilities. We discuss practical
implications of these findings for applied Mendelian randomization investigations.
Software code in the R programming language for implementing the analyses discussed
in the paper is provided in the Appendix.
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Motivating example: serum testosterone and coro-
nary heart disease risk
We consider an example Mendelian randomization analysis with serum testosterone
as the risk factor and coronary artery disease (CAD) risk as the outcome using ge-
netic variants in the SHBG gene region. The associations of 325 individual SNPs with
testosterone are reported by Jin et al. [2012]; associations of 322 of these variants with
coronary artery disease risk are reported by the CARDIoGRAMplusC4D Consortium
[2015]. Previously, in an independent dataset, Coviello et al. [2012] demonstrated at
least six separate signals in the SHBG gene region at a genome-wide level of signifi-
cance, plus three more variants associated with sex hormone-binding globulin (SHBG)
on adjustment for these six variants. In all analyses, correlations between variants
are estimated using 1000 Genomes Phase 3 data on 503 individuals of European de-
scent as reference data. A further 2 variants were monomorphic in the reference data;
analyses are conducted using the remaining 320 variants. As variants in the SHBG
gene region are associated with circulating levels of both testosterone and SHBG, a
positive Mendelian randomization finding would not distinguish which of these is a
causal risk factor, but would suggest that sex hormone-related mechanisms have a
causal role in cardiovascular disease.
Three approaches are taken here to choose which variants to include in a Mendelian
randomization analysis. First, we take eight variants from the conditional analysis in
the independent dataset reported by Coviello et al. (the association with testosterone
in the data under analysis was not available for one variant). Second, we perform
a stepwise conditional approach using the summarized associations reported by Jin
et al., selecting at each step of the analysis the variant having the lowest p-value
for association with the risk factor in the conditional analysis. We proceed until no
additional variants are associated with the risk factor at p < 0.0001 or p < 0.001.
This approach is implemented using the GCTA software. Third, we perform a step-
wise pruning approach [Yang et al., 2012], selecting at each step of the analysis the
variant having the lowest p-value for association with the risk factor in a marginal
(univariable) analysis. Once a variant is selected, all other variants whose correlation
with the selected variant is greater in magnitude than a given correlation threshold
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(taken as 0.2, 0.4, 0.6, 0.8, 0.9, and 0.95; equivalent to an r2 threshold of 0.04, 0.16,
0.36, 0.64, 0.81 and 0.9025) are removed from the analysis. We continue until each
variant is either selected or removed. This ensures that a set of variants is chosen
for each threshold correlation such that the variants are each marginally associated
with the risk factor, and the pairwise correlations are all below the threshold correla-
tion. Although a data-driven approach to selecting variants to include in a Mendelian
randomization investigation is often unwise [Burgess et al., 2011], in this case the as-
sociations with the risk factor and with the outcome are estimated in non-overlapping
samples, and so “winner’s curse” bias in the genetic associations with the outcome
should not arise.
The Mendelian randomization estimates are presented in Table I. Fixed-effect anal-
ysis models that account for correlations between variants are used throughout. De-
spite the two approaches using a conditional analysis and the pruning approach at a
threshold correlation of 0.2 including similar numbers of variants in the analysis, the
causal estimates in these three analyses differed substantially – by over two standard
errors, and gave opposing substantive conclusions. In the pruning approach, as the
threshold correlation increased, more variants were included in the Mendelian ran-
domization analysis, and the precision of the causal estimate increased. However, for
very large values of the threshold correlation, the standard error of the causal estimate
is implausibly small. With a threshold correlation of 0.9, the standard error of the
causal estimate was not defined due to the variance estimate being negative. With a
threshold correlation of 0.95, the causal estimate is clearly spurious, as can be seen
by visual inspection of the data (Figure 1, left panel). The result with a correlation
of 0.8 is also suspect (Figure 1, right panel), as the variants having the greatest as-
sociations with testosterone all lie above the causal effect estimate. Even at lower
threshold correlations of 0.4 and 0.6, the standard errors of the causal estimate are
substantially lower than those calculated using the conditional approach. This may
be due to the extra variants explaining additional variability in the risk factor; the re-
duction in standard error corresponds to a 97% relative increase in variance explained
by the variants at a threshold of 0.4 compared with at 0.2, and a 240% increase at
a threshold of 0.6. It is unclear which of the estimates in Table I are reliable, and
therefore whether evidence supports testosterone as a causal risk factor for coronary
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heart disease risk or not.
Table I: Estimates in motivating example
Selection Threshold correlation Number of
approach ρ r2 variants Estimate (SE)
Conditional analysis in
- - 8 -0.258 (0.097)
independent dataset (Coviello)
GCTA at p < 0.0001 - - 6 -0.009 (0.058)
GCTA at p < 0.001 - - 19 -0.068 (0.042)
Pruning 0.2 0.04 8 -0.110 (0.094)
Pruning 0.4 0.16 20 -0.085 (0.067)
Pruning 0.6 0.36 39 -0.017 (0.051)
Pruning 0.8 0.64 62 -0.137 (0.031)
Pruning 0.9 0.81 85 -0.537 (-) a
Pruning 0.95 0.9025 104 -1.099 (0.001)
Estimates (standard errors, SE) of causal effect of testosterone on coronary artery disease
risk (estimates are log odds ratios per unit increase in log-transformed testosterone) from
inverse-variance weighted method (accounting for correlation) with variants selected using
three different approaches and (for the pruning method) six different threshold correlations
(measured by ρ and by r2).
aThe variance estimate was negative, indicating that the weighting matrix was not positive defi-
nite, meaning that either the standard errors in the weighting matrix were imprecisely estimated, or
else were not compatible with the correlation matrix.
Choosing the right number of variants
To resolve the question of how to choose which variants to include in a Mendelian
randomization analysis, we explore reasons why analyses that include too many or
too few genetic variants may go wrong, and propose a solution that incorporates
associations on large numbers of genetic variants into the analysis, but does not suffer
from numerical instabilities.
Too many variants: near-singular genetic correlation matrix
A matrix is singular if it cannot be inverted – formally, if the determinant of the matrix
is zero. This occurs when the rows or columns of a matrix are linearly dependent; that
8
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Figure 1: Estimated genetic associations and 95% confidence intervals with testos-
terone (nmol/L, then log-transformed) and with coronary artery disease risk (log odds
ratios): (left) for 104 genetic variants included in Mendelian randomization analysis
with threshold correlation 0.95 (r2 = 0.9025); (right) for 62 genetic variants with
threshold correlation 0.8 (r2 = 0.64). The heavy dashed line is the inverse-variance
weighted estimate (accounting for correlation between variants).
is, at least one column (or row) can be calculated as a linear sum of multiples of the
other columns (known as multicollinearity). This will occur for the genetic correlation
matrix when two genetic variants are in perfect linkage disequilibrium, or alternatively
if a small number of haplotypes are present in the data (perfect multicollinearity can
occur even if no pair of variants is highly correlated). In contrast, a near-singular
matrix can be inverted, but its determinant is close to zero. This occurs in a regression
model when there is substantial, but not perfect, multicollinearity. As sample sizes for
estimating genetic correlations increase, singular matrices will become less common,
but near-singular genetic correlation matrices are likely to become more common.
This is because a discrepant allele count in a single individual (which could represent
a genotyping error) can lead to a singular matrix becoming non-singular. A near-
singular matrix is problematic as elements of its inverse can be very large. In the
motivating example with correlation thresholds of 0.9 and 0.95, the maximal element
of the inverse of the correlation matrix is over 10 million.
If a matrix is exactly singular, then it cannot be inverted, and the analysis will
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report an error. If a matrix is near-singular, then the analysis may report an estimate
without giving any indication that the estimate may be misleading (as observed in
Figure 1). In conjunction with discrepancies in the genetic association estimates, near-
singular behaviour can lead to overly-precise as well as highly misleading estimates.
Discrepancies may occur due to include rounding of association estimates (particularly
for summarized genetic associations taken from the literature), inaccuracy and uncer-
tainty in correlation estimates, and genetic association estimates and/or correlation
estimates being estimated in different samples. When multiplied by the large num-
bers in the inverse of a near-singular genetic correlation matrix, small discrepancies in
association estimates are magnified. Overprecision in the causal estimate will occur
when genetic association estimates that should be similar based on the correlation
matrix are more dissimilar than expected.
Too few variants: unstable estimates
While theoretical considerations suggest that a Mendelian randomization analysis
should be based on only variants associated with the risk factor in a conditional anal-
ysis, in practice this results in a Mendelian randomization estimate that only uses
data on a small number of variants. In the motivating example, the conditional anal-
yses suggest that less than 10 variants should be included in the analysis; associations
with the remaining over 300 variants are ignored. In some cases and in particular in
the motivating example, the causal estimate is highly sensitive to the choice of which
variants are included in the analysis. This leads to unstable Mendelian randomization
estimates – if one of the selected variants in the conditional analysis happened not
to be measured, or failed quality control (QC) criteria, then a different set of vari-
ants would have been obtained from the conditional analysis, resulting in a different
Mendelian randomization estimate.
Just right?: principal components analysis
One potential solution for resolving the problem of multiple correlated variants is prin-
cipal components analysis (PCA). The use of PCA has been previously suggested for
reducing the dimensionality of the instrumental variable space to resolve issues of weak
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instrument bias [Winkelried and Smith, 2011], and as a tool for grouping variants in a
fine-mapped gene region [Cai et al., 2013]. We perform unscaled PCA on a weighted
version of the genetic correlation matrix Ψj1j2 = βˆXj1βˆXj2 se(βˆY j1)
−1 se(βˆY j2)
−1ρj1j2.
The diagonal elements of this matrix are the inverse-variance weights, and so each is
equal to the precision of the causal estimate based on that variant alone.
Assuming that associations for all variants are estimated in the same sample size,
these diagonal elements are proportional to the amount of variance in the risk fac-
tor explained by the genetic variant. This can be seen as the standard errors of the
associations with the outcome will be directly proportional to the standard errors of
the associations with the risk factor, which in turn relate to the minor allele frequen-
cies MAFj : if the variant is a diallelic SNP, then se(βˆXj)
−2
∝ MAFj(1 − MAFj)
[Burgess et al., 2016]. (The proportion of variance in the risk factor explained by ge-
netic variant j is β2Xj×MAFj(1−MAFj), where βXj is measured in standard deviation
units.) Hence, if the variants were uncorrelated, then the first principal component
would be the genetic variant that explained the largest proportion of variance in the
risk factor, and so on. For correlated variants, the first principal component represents
a linear combination of variants that explains the largest proportion of variance in
the risk factor, and each subsequent principal component is the linear combination of
variants that explains the next largest proportion of variance while being orthogonal
to the previous principal components.
This choice of matrix should be advantageous for Mendelian randomization in-
vestigations over PCA approaches on the unweighted matrix of genetic correlations.
If two variants are perfectly correlated, but the estimates for one are measured in a
larger sample size, then the precision of the association with the outcome (se(βˆY j)
−1)
will be greater for this variant, and so it will (correctly) be preferentially selected. The
number of principal components to be included in the analysis can be chosen based on
a threshold of variance in the weighted genetic correlation matrix. Once the principal
components have been selected, we multiply the vector of genetic associations with the
risk factor by the matrix of principal components, we multiply the vector of genetic
associations with the outcome by the matrix of principal components, and pre- and
post-multiply the genetic correlation matrix by the matrix of principal components.
The IVW method is then performed on the transformed vectors of genetic associations
11
and the transformed correlation matrix. If the matrix Ψ = WΛW T , where W is the
matrix of eigenvectors (or loadings), and Λ is the diagonal matrix with the eigenvalues
λ1 > . . . > λJ on the diagonal, then let Wk be the matrix constructed of the first k
columns of W . Then we define:
β˜X = W
T
k βˆX as the transformed genetic associations with the risk factor
β˜Y = W
T
k βˆY as the transformed genetic associations with the outcome
Ω˜ = W Tk ΩWk as the transformed weighting matrix.
Then the PCA-IVW estimate is given by:
(β˜
T
XΩ˜
−1β˜X)
−1β˜
T
XΩ˜
−1β˜Y (3)
For the example of testosterone and CAD risk, 99% of the variance in this matrix
was explained by the first 8 principal components, and 99.9% by the first 17 princi-
pal components. The corresponding estimates using these principal components as
instruments were -0.065 (standard error 0.099) and -0.045 (0.083) respectively. These
estimates are similar in precision to that using the previous conditional analysis for
variable selection, but less precise than those calculated using the GCTA method on
the data under analysis or a liberal correlation threshold in the pruning method.
Simulation study
We illustrate statistical issues arising from using too many and too few variants in
a series of simulation studies based on the motivating example. Again, fixed-effect
analysis models are used throughout.
Sensitivity to choice of genetic variants
First, we repeated the analyses of the motivating example except using only 180 of
the 360 genetic variants at a time. This represents a scenario in which only a subset
of the genetic variants in the analysis were measured. Sets of 180 variants were chosen
at random 10 000 times.
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Sensitivity to correlation matrix
Second, we repeated the analyses of the motivating example except varying the cor-
relation matrix. We took a bootstrap sample of the reference data (same size sample
as the original data, sampled with replacement), and calculated a correlation matrix
based on this sample. This procedure was performed 10 000 times.
For each of these simulation analyses, we performed the pruning method for se-
lecting genetic variants at a threshold correlation of 0.2, 0.4, 0.6 and 0.8, and the
PCA method using components that explained 99% and 99.9% of the variance in the
summarized association matrix. Results are presented in Table II. In both simulation
studies, as the threshold in the pruning approaches increased, the mean standard error
of the causal estimates decreased, and the mean causal estimate also changed sub-
stantially. For a threshold correlation of ρ = 0.8, causal estimates were unstable, and
were particularly sensitive to changes in the correlation matrix. In contrast, estimates
using the PCA approach were not so precise, but they were far less variable between
iterations.
Table II: Simulations varying choice of variants and correlation matrix
Varying choice of variants Varying correlation matrix
Selection approach Mean estimate SD Mean SE Mean estimate SD Mean SE
Pruning at ρ = 0.2 -0.100 0.044 0.094 -0.114 0.035 0.090
Pruning at ρ = 0.4 -0.093 0.032 0.078 -0.074 0.027 0.065
Pruning at ρ = 0.6 -0.009 0.049 0.060 -0.018 0.052 0.046
Pruning at ρ = 0.8 -0.024 0.402 0.048 a - b - -
PCA at 99% of variance -0.053 0.028 0.098 -0.051 0.027 0.096
PCA at 99.9% of variance -0.045 0.025 0.084 -0.047 0.017 0.083
Means of estimates, standard deviations (SD) of estimates, and mean standard er-
rors (SE) for 10 000 iterations based on motivating example: i) varying the choice of
variants and ii) varying the correlation matrix. Six approaches for selecting genetic
variants are performed: four based on pruning at different correlation thresholds (ρ)
and two based on principal components analysis (PCA).
aExcluding 536 iterations in which the standard error was not defined.
bEstimates were highly variable and the standard error was not defined for a large proportion of
iterations.
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Rounding of association estimates
Finally, we simulated genetic associations with the risk factor and with the outcome
directly. Genetic associations with the risk factor were drawn for 320 variants from a
multivariable normal distribution with mean vector the measured genetic associations
with testosterone from the motivating example and variance-covariance matrix ΩX ,
where ΩXj1j2 = se(βˆXj1) se(βˆXj2)ρj1j2. The associations with the outcome are drawn
from a multivariate normal distribution with mean zero and variance-covariance ma-
trix Ω, where Ωj1j2 = se(βˆY j1) se(βˆY j2)ρj1j2 as defined above. This represents a null
causal effect. We also set the mean of the distribution of the associations with the
outcome as 0.1 times the associations with the risk factor, representing a causal effect
of 0.1. We simulated 10 000 datasets for each value of the causal effect, and calculated
the Mendelian randomization estimate using the same six approaches for variant se-
lection as above. Additionally, we repeated the analyses but first rounding the genetic
associations (and their standard errors) to three and two decimal places.
Results
Results are presented in Table III for the standard deviation of estimates, the mean
standard error, and the empirical power of the 95% confidence interval (the proportion
of datasets in which the confidence interval excluded the null; this is the Type 1 error
rate for a null causal effect). The mean estimates (not presented) were close to the true
causal effect throughout for all approaches. As in the previous simulations, estimates
from the pruning approach became more precise as the threshold correlation increased,
although Type 1 error rates were above nominal levels for ρ = 0.8 even when the
association estimates were not rounded. Rounding exacerbated false positive findings,
and inflated Type 1 error rates were present in all methods when associations were
rounded to 2 decimal places. Coverage rates were least affected when pruning at a
threshold correlation of ρ = 0.2 or 0.4 and for the PCA approaches. With a positive
causal effect, power increased as the threshold increased, although judging estimators
by power estimates is misleading when Type 1 error rates are inflated. Power of
the PCA approaches was similar to that using a pruning threshold of ρ = 0.2, and
was greater using principal components that explained a greater proportion of the
14
weighted correlation matrix.
Table III: Simulation rounding association estimates
Unrounded 3 decimal places 2 decimal places
Selection approach SD Mean SE Power SD Mean SE Power SD Mean SE Power
Null causal effect
Pruning at ρ = 0.2 0.080 0.079 5.0 0.080 0.080 4.9 0.086 0.077 7.3
Pruning at ρ = 0.4 0.067 0.066 5.0 0.067 0.066 5.1 0.073 0.063 9.2
Pruning at ρ = 0.6 0.049 0.049 5.0 0.050 0.050 4.9 0.066 0.047 16.5
Pruning at ρ = 0.8 0.027 0.022 10.5 0.175 0.022 40.8 0.418 0.020 62.2
PCA at 99% of variance 0.089 0.090 4.6 0.090 0.090 4.6 0.094 0.083 8.0
PCA at 99.9% of variance 0.075 0.075 4.6 0.075 0.076 4.5 0.079 0.069 9.0
Positive causal effect of 0.1
Pruning at ρ = 0.2 0.080 0.079 24.8 0.080 0.080 24.6 0.086 0.077 27.9
Pruning at ρ = 0.4 0.067 0.066 33.6 0.067 0.066 33.2 0.073 0.063 37.0
Pruning at ρ = 0.6 0.049 0.049 54.3 0.050 0.050 51.9 0.066 0.047 53.1
Pruning at ρ = 0.8 0.027 0.022 88.8 0.172 0.022 86.7 0.644 0.020 79.3
PCA at 99% of variance 0.089 0.090 19.6 0.090 0.090 19.5 0.095 0.083 25.1
PCA at 99.9% of variance 0.075 0.075 26.1 0.075 0.076 25.6 0.079 0.069 32.6
Standard deviations (SD) of estimates, mean standard errors (SE), and empirical power based
on the 95% confidence interval for 10 000 simulated datasets using six approaches for selecting
genetic variants. Results are also given on rounding the association estimates to a fixed number
of decimal places.
Discussion
As the cost of high-density genome sequencing continues to fall, additional signals are
likely to be identified within known loci. There will be growing demand for meth-
ods to exploit correlated instruments in Mendelian randomization, as the addition of
correlated variants can improve power to detect a causal effect. In this paper, we
first connected previously known results together to show from theoretical arguments
that genetic variants included in a Mendelian randomization analysis should be those
that are associated with the risk factor in a conditional analysis. If the variants are
combined in an allele score, then the conditional (multivariable) associations with
the risk factor should be used as weights in the allele score to obtain the most ef-
ficient analysis. If only summarized data are available, then the same analysis can
15
be replicated with the marginal (univariable) associations using an extension to the
inverse-variance weighted method to account for correlations between variants.
However, difficulties arise when there are many correlated genetic variants in a sin-
gle gene region that are associated with the risk factor (fine-mapping genetic data).
Including too few genetic variants in an analysis means that estimates are less pre-
cise, but also highly variable, in that different approaches to choosing variants can
lead to markedly different estimates. However, including too many variants can lead
to numerical instabilities and overly precise estimates with inflated Type 1 error rates.
These numerical instabilities are not computational issues, but arise due to inconsis-
tencies in the data: for example, if association estimates are rounded to a fixed number
of decimal places, or if association or correlation estimates are obtained in different
samples. It is difficult in practice to judge at what threshold these numerical issues
begin to occur, although in the simulation examples considered, problems regularly
occurred when pruning variants at a threshold correlation of 0.8 (r2 = 0.64), and
occasionally occurred at a threshold correlation of 0.6 (r2 = 0.36). We note as well
that r2 is not always a good measure of correlation between genetic variants; near-
singular matrices can occur when the pairwise correlations measured by r2 are low
but there are haplotypes represented in the data, or when the minor allele frequencies
of variants differ but a common variant ‘tags’ a rare variant (high D-prime, but low
r2).
As an alternative approach, we have proposed a method for selecting instruments
based on principal components analysis of a weighted version of the genetic correla-
tion matrix. This approach constructs instruments as linear combinations of genetic
variants. As the linear combinations are orthogonal, the approach does not suffer as
much with respect to numerical instabilities. Additionally, the method incorporates
data on all the genetic variants into the analysis, and consequently causal estimates
from the approach are less variable. Estimates from the principal components analysis
approach are less precise than those from the variable selection approaches considered
here (GCTA and pruning); however, they are less variable with respect to choices of
how to implement the analysis (in particular the choice of variants).
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Comparison with previous work
The inverse-variance weighted method presented here is a simple application of gen-
eralized weighted linear regression, and is not unique to Mendelian randomization.
The same method has been used in a variety of contexts including discovery genetics
[Zhu et al., 2016], and prediction and model selection [Chen et al., 2015; Benner et al.,
2016; Newcombe et al., 2016]. A number of different solutions have been proposed to
the problem of highly-correlated variants, including pruning and clumping at a thresh-
old correlation, and adding a small positive number to the diagonal of the correlation
matrix [Gusev et al., 2016]. In the applied example of the paper at a correlation
threshold of ρ = 0.8, adding 0.1 to the diagonal of the correlation matrix changed
the causal estimate from -0.137 (standard error 0.031) to -0.065 (0.057). Although
the substantial change in the causal estimate is indicative of near-singular behaviour,
it would seem preferable for estimation to simply use a stricter correlation threshold
rather than misspecifying the correlation matrix (and better still to use the principal
component approach presented in this manuscript).
We believe that Mendelian randomization differs somewhat from other analysis
contexts, as an instrumental variable analysis relies on inferences from a single gene
region (for example, for a protein risk factor where the gene region is the coding region
for the risk factor) or a small number of gene regions. Another feature of Mendelian
randomization is the prevalence of the summarized data and two-sample settings, in
which discrepancies in genetic associations are likely to arise.
Principal components approaches have been suggested before for fine-mapping
data, with Wallace demonstrating that 70% of the variance in the genetic correlation
matrix could be explained by an average of 7 components for 49 test gene regions
[Wallace, 2013]. A key innovation here is weighting the genetic correlation matrix,
meaning that principal components with the greatest eigenvalues will be those that
explain the most variance in the risk factor. This means that it is more likely that an
analysis based on a small number of principal components will have reasonable power
to detect a causal effect. For example, if there is only one causal variant in the gene
region, then 100% of the variance would be explained by one principal component,
even if there were other uncorrelated variants in the gene region.
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We advocate the principal components analysis method proposed in this paper as
a worthwhile approach to analyse fine-mapped genetic data for Mendelian random-
ization.
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Figure legends
Figure 1: Estimated genetic associations and 95% confidence intervals with
testosterone (nmol/L, then log-transformed) and with coronary artery disease risk
(log odds ratios): (left) for 104 genetic variants included in Mendelian randomiza-
tion analysis with threshold correlation 0.95 (r2 = 0.9025); (right) for 62 genetic
variants with threshold correlation 0.8 (r2 = 0.64). The heavy dashed line is the
inverse-variance weighted estimate (accounting for correlation between variants).
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Appendix
A.1 Software code
We provide R code to implement the methods discussed in this paper. The genetic
variants are represented by g (a matrix of allele counts for the genetic variants), the
risk factor by x, and the outcome by y. Weights for the allele score are represented by
wts. The associations of the candidate instruments with the risk factor are denoted
betaXG with standard errors sebetaXG. The associations of the candidate instruments
with the outcome are denoted betaYG with standard errors sebetaYG. With a contin-
uous outcome, these associations are usually estimated using linear regression; with a
binary outcome, using logistic regression.
The two-stage least squares (2SLS) method can be implemented using the sem
package:
library(sem)
beta_2sls = tsls(y, cbind(x, rep(1,parts)), cbind(g, rep(1,parts)),
w=rep(1, parts))$coef[1]
# w are the weights in the two-stage least squares method
# (w is set to one for all individuals)
# the cbind(..., rep(1,parts)) ensures that a constant term is
# included in both regression stages of the 2SLS method
se_2sls = sqrt(tsls(y, cbind(x, rep(1,parts)), cbind(g, rep(1,parts)),
w=rep(1, parts))$V[1,1])
Genetic variants can be collapsed into an allele score, and the score can be used
in the 2SLS method:
library(sem)
score = g%*%wts
beta_score = tsls(y, cbind(x, rep(1,parts)), cbind(score, rep(1,parts)),
w=rep(1, parts))$coef[1]
se_score = sqrt(tsls(y, cbind(x, rep(1,parts)), cbind(score, rep(1,parts)),
w=rep(1, parts))$V[1,1])
If the genetic variants are perfectly uncorrelated, and the weights are the coeffi-
cients from univariable regression analyses of the risk factor on each of the genetic
variants in turn, then these two analyses are equivalent.
Inverse-variance weighted estimate (ignoring correlation):
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beta_IVW = summary(lm(betaYG~betaXG-1, weights=sebetaYG^-2))$coef[1]
se_IVW.fixed = summary(lm(betaYG~betaXG-1, weights=sebetaYG^-2))$coef[1,2]/
summary(lm(betaYG~betaXG-1, weights=sebetaYG^-2))$sigma
se_IVW.random = summary(lm(betaYG~betaXG-1, weights=sebetaYG^-2))$coef[1,2]/
max(summary(lm(betaYG~betaXG-1, weights=sebetaYG^-2))$sigma,1)
Although fixed-effects models are used throughout this paper, the (multiplicative)
random-effects analysis is preferred when heterogeneity between the causal estimates
from each genetic variant is expected (provided that there are enough genetic variants
in the model to obtain a reasonable estimate of the heterogeneity). Heterogeneity
would generally be expected when using genetic variants from multiple gene regions
that may have different mechanisms of influencing the risk factor, but not when using
multiple variants in the same gene region that should have similar mechanisms of
effect.
Inverse-variance weighted estimate (accounting for correlation):
Omega = sebetaYG%o%sebetaYG*rho
beta_IVWcorrel = solve(t(betaXG)%*%solve(Omega)%*%betaXG)*t(betaXG)%*%solve(Omega)%*%betaYG
se_IVWcorrel.fixed = sqrt(solve(t(betaXG)%*%solve(Omega)%*%betaXG))
resid = betaYG-beta_IVWcorrel*betaXG
se_IVWcorrel.random = sqrt(solve(t(betaXG)%*%solve(Omega)%*%betaXG))*
max(sqrt(t(resid)%*%solve(Omega)%*%resid/(length(betaXG)-1)),1)
The matrix rho comprises the pairwise correlations between the genetic associa-
tions (in particular, the genetic associations with the outcome). Provided that are
genetic associations estimated in the same participants, these are equal to the corre-
lations between the genetic variants themselves.
Inverse-variance weighted estimate (accounting for correlation) using principal
components:
Phi = (betaXG/sebetaYG)%o%(betaXG/sebetaYG)*rho
summary(prcomp(Phi, scale=FALSE))
K = which(cumsum(prcomp(Phi, scale=FALSE)$sdev^2/sum((prcomp(Phi, scale=FALSE)$sdev^2)))>0.99)[1]
# K is number of principal components to include in analysis
# this code includes principal components to explain 99% of variance in the risk factor
betaXG0 = as.numeric(betaXG%*%prcomp(Phi, scale=FALSE)$rotation[,1:K])
betaYG0 = as.numeric(betaYG%*%prcomp(Phi, scale=FALSE)$rotation[,1:K])
Omega = sebetaYG%o%sebetaYG*rho
pcOmega = t(prcomp(Phi, scale=FALSE)$rotation[,1:K])%*%Omega%*%prcomp(Phi, scale=FALSE)$rotation[,1:K]
beta_IVWcorrel.pc = solve(t(betaXG0)%*%solve(pcOmega)%*%betaXG0)*t(betaXG0)%*%solve(pcOmega)%*%betaYG0
se_IVWcorrel.fixed.pc = sqrt(solve(t(betaXG0)%*%solve(pcOmega)%*%betaXG0))
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The inverse-variance weighted method accounting for correlation can also be per-
formed using the standard linear regression command after weighting the data by a
Cholesky decomposition:
Omega = sebetaYG%o%sebetaYG*rho
c_betaXG = solve(t(chol(Omega)))%*%betaXG
c_betaYG = solve(t(chol(Omega)))%*%betaYG
beta_IVWcorrel = lm(c_betaYG~c_betaXG-1)$coef[1]
se_IVWcorrel.fixed = sqrt(1/(t(betaXG)%*%solve(Omega)%*%betaXG))
se_IVWcorrel.random = sqrt(1/(t(betaXG)%*%solve(Omega)%*%betaXG))*max(summary(lm(c_betaYG~c_betaXG-1))$sigma,1)
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A.2 Proof of equality of 2SLS and inverse-variance weighted
estimates
Variants uncorrelated: If the we write the risk factor as X (usually an N × 1
matrix, although the result can be generalized for multiple risk factors), the outcome
as Y (an N ×1 matrix), and the instrumental variables as Z (an N ×J matrix), then
the two-stage least squares estimate of causal effects is:
βˆ2SLS = [X
TZ(ZTZ)−1ZTX ]−1XTZ(ZTZ)−1ZTY.
This estimate can be obtained by sequential regression of the risk factor on the in-
strumental variables, and then the outcome on fitted values of the risk factor from
the first-stage regression.
Regression of Y on Z gives beta-coefficients βˆY = (Z
TZ)−1ZTY with standard
errors the square roots of the diagonal elements of the matrix (ZTZ)−1σ2 where σ is
the residual standard error. If the instrumental variables are perfectly uncorrelated,
then the off-diagonal elements of (ZTZ)−1σ2 are all equal to zero. Regression of
X on Z gives beta-coefficients βˆX = (Z
TZ)−1ZTX . Weighted linear regression of
the beta-coefficients βˆY on the beta-coefficients βˆX using the inverse-variance weights
(ZTZ)σ−2 gives an estimate:
[βˆTX(Z
TZ)βˆX ]
−1σ−2βˆTX(Z
TZ)σ2βˆY
=[XTZ(ZTZ)−1(ZTZ)(ZTZ)−1ZTX ]−1XTZ(ZTZ)−1(ZTZ)(ZTZ)−1ZTY
=[XTZ(ZTZ)−1ZTX ]−1XTZ(ZTZ)−1ZTY
=βˆ2SLS
The assumption of uncorrelated instrumental variables ensures that the regression
coefficients from univariate regressions (as in the regression-based methods) equal
those from multivariable regression (as in the two-stage least squares method).
Variants correlated: If the variants are correlated, then the same argument
holds, except that the weights in the weighted linear regression of the beta-coefficients
βˆY on the beta-coefficients βˆX are (Z
TZ)Pσ−2, where P is the (symmetric) correlation
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matrix.
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